Brief Report: Exploratory Substudy of a Phase 2 Trial to Evaluate the Pharmacokinetic Effect of Once-Monthly Islatravir on Long-Acting Reversible Contraceptives. [PDF]
Pham M +7 more
europepmc +1 more source
Evaluation of pharmacokinetic interactions between long-acting cabotegravir or emtricitabine/tenofovir disoproxil fumarate and hormonal contraceptive agents: a tertiary analysis of South African participants in HPTN 084. [PDF]
Marzinke MA +21 more
europepmc +1 more source
Megestrol acetate (MA), d-norgestrel (d-Ng) and norethindrone (NET) contained in Silastic capsules were implanted under the skin for clinical evaluation as a long-term contraceptive in women. Woman-mo.
KAPLAN, E +7 more
core
Safety of 48 months of elagolix with add-back therapy for endometriosis-associated pain. [PDF]
Kim JH +5 more
europepmc +1 more source
Combined Oral Contraceptive Pills Versus Progestin-Only Pills for Heavy Menstrual Bleeding: A Systematic Review. [PDF]
Mohamed GS +8 more
europepmc +1 more source
Bone mineral density with elagolix plus add-back therapy in women with heavy menstrual bleeding and uterine fibroids: open-label and post-treatment results of a 60-month phase 3 trial. [PDF]
Schnell VL +6 more
europepmc +1 more source
Managing Abnormal Uterine Bleeding With Norethisterone Acetate: An Evidence-Based Review and Expert Insights. [PDF]
Divakar H +11 more
europepmc +1 more source
Effects of Ensitrelvir on the Pharmacokinetics of Combined Oral Contraceptives (Ethinyl Estradiol/Drospirenone) in Healthy Adult Women: A Phase 1 Fixed-Sequence, Multiple-Dose, Drug-Drug Interaction Study. [PDF]
Shimizu R +4 more
europepmc +1 more source
An Overview of Endometriosis and Potential Pharmacogenetic Targets. [PDF]
Pérez-Gómez N +6 more
europepmc +1 more source

